Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 8, Issue 1
1 January 2002
Issue Cover
All Issues
ISSN 1078-0432
EISSN 1557-3265

Editorials

Lung Cancer Prevention: Retinoids and the Epidermal Growth Factor Receptor—A Phoenix Rising?
Steven D. Averbuch
View articletitled, Lung Cancer Prevention<span class="subtitle-colon">: </span><span class="subtitle">Retinoids and the Epidermal Growth Factor Receptor—A Phoenix Rising?</span>
Open the PDF for in another window
Membrane Transport of Chemotherapeutics and Drug Resistance: Beyond the ABC Family of Exporters to the Role of Carrier-mediated Processes
I. David Goldman
View articletitled, Membrane Transport of Chemotherapeutics and Drug Resistance<span class="subtitle-colon">: </span><span class="subtitle">Beyond the ABC Family of Exporters to the Role of Carrier-mediated Processes</span>
Open the PDF for in another window
Mechanisms Underlying Chemoprevention of Ovarian Cancer
Gordon B. Mills
View articletitled, Mechanisms Underlying Chemoprevention of Ovarian Cancer
Open the PDF for in another window

Special Article

Cancer Prevention: Past, Present, and Future 1
Robert C. Young; Christine M. Wilson
View articletitled, Cancer Prevention<span class="subtitle-colon">: </span><span class="subtitle">Past, Present, and Future <sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup></span>
Open the PDF for in another window

The Biology Behind

The Potential Prognostic, Predictive, and Therapeutic Values of DNA Methylation in Cancer1: Commentary re: J. Kwong et al., Promoter Hypermethylation of Multiple Genes in Nasopharyngeal Carcinoma. Clin. Cancer Res., 8: 131–137, 2002, and H-Z. Zou et al., Detection of Aberrant p16 Methylation in the Serum of Colorectal Cancer Patients. Clin. Cancer Res., 8: 188–191, 2002.
Martin Widschwendter; Peter A. Jones
View articletitled, The Potential Prognostic, Predictive, and Therapeutic Values of DNA Methylation in Cancer<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup><span class="subtitle-colon">: </span><span class="subtitle">Commentary re: J. Kwong <strong><em>et al.</em></strong>, Promoter Hypermethylation of Multiple Genes in Nasopharyngeal Carcinoma. Clin. Cancer Res., <strong><em>8:</em></strong> 131–137, 2002, and H-Z. Zou <strong><em>et al.</em></strong>, Detection of Aberrant p16 Methylation in the Serum of Colorectal Cancer Patients. Clin. Cancer Res., <strong><em>8:</em></strong> 188–191, 2002.</span>
Open the PDF for in another window

Advances in Brief

Molecular Oncology, Markers, Clinical Correlates
The Multidrug Resistance Transporter ABCG2 (Breast Cancer Resistance Protein 1) Effluxes Hoechst 33342 and Is Overexpressed in Hematopoietic Stem Cells
Min Kim; Heth Turnquist; John Jackson; Magda Sgagias; Ying Yan; Maokai Gong; Michael Dean; John G. Sharp; Kenneth Cowan
View articletitled, The Multidrug Resistance Transporter ABCG2 (Breast Cancer Resistance Protein 1) Effluxes Hoechst 33342 and Is Overexpressed in Hematopoietic Stem Cells
Open the PDF for in another window
Diagnostic and Prognostic Implications of Circulating Cell-free Epstein-Barr Virus DNA in Natural Killer/T-Cell Lymphoma
Kenny I. K. Lei; Lisa Y. S. Chan; Wing-Yee Chan; Philip J. Johnson; Y. M. Dennis Lo
View articletitled, Diagnostic and Prognostic Implications of Circulating Cell-free Epstein-Barr Virus DNA in Natural Killer/T-Cell Lymphoma
Open the PDF for in another window
Microsatellite Analysis of Free Tumor DNA in Urine, Serum, and Plasma of Patients: A Minimally Invasive Method for the Detection of Bladder Cancer
Michael Utting; Wolfram Werner; Regine Dahse; Jörg Schubert; Kerstin Junker
View articletitled, Microsatellite Analysis of Free Tumor DNA in Urine, Serum, and Plasma of Patients<span class="subtitle-colon">: </span><span class="subtitle">A Minimally Invasive Method for the Detection of Bladder Cancer</span>
Open the PDF for in another window
Identification and Characterization of a Human Agonist Cytotoxic T-Lymphocyte Epitope of Human Prostate-specific Antigen
Hiroshi Terasawa; Kwong-Yok Tsang; James Gulley; Philip Arlen; Jeffrey Schlom
View articletitled, Identification and Characterization of a Human Agonist Cytotoxic T-Lymphocyte Epitope of Human Prostate-specific Antigen
Open the PDF for in another window
Evidence for the Epidermal Growth Factor Receptor As a Target for Lung Cancer Prevention1
Fulvio Lonardo; Konstantin H. Dragnev; Sarah J. Freemantle; Yan Ma; Natalie Memoli; David Sekula; Elisabeth A. Knauth; Jean S. Beebe; Ethan Dmitrovsky
View articletitled, Evidence for the Epidermal Growth Factor Receptor As a Target for Lung Cancer Prevention<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Cancer Biology, Immunology, Cytokines
Contrasting Expression of Thrombospondin-1 and Osteopontin Correlates with Absence or Presence of Metastatic Phenotype in an Isogenic Model of Spontaneous Human Breast Cancer Metastasis
Virginia Urquidi; Derek Sloan; Kanji Kawai; Dianne Agarwal; Anthony C. Woodman; David Tarin; Steve Goodison
View articletitled, Contrasting Expression of Thrombospondin-1 and Osteopontin Correlates with Absence or Presence of Metastatic Phenotype in an Isogenic Model of Spontaneous Human Breast Cancer Metastasis
Open the PDF for in another window

Regular Articles

Clinical Trials
A Phase I and Pharmacokinetic Study of Ecteinascidin-743 on a Daily × 5 Schedule in Patients with Solid Malignancies1
Miguel A. Villalona-Calero; S. Gail Eckhardt; Geoffrey Weiss; Manuel Hidalgo; Jos H. Beijnen; Charlotte van Kesteren; Hilde Rosing; Elizabeth Campbell; Maura Kraynak; Luis Lopez-Lazaro; Cecilia Guzman; Daniel D. Von Hoff; Jose Jimeno; Eric K. Rowinsky
View articletitled, A Phase I and Pharmacokinetic Study of Ecteinascidin-743 on a Daily × 5 Schedule in Patients with Solid Malignancies<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Phase I and Pharmacokinetic Study of a Micronized Formulation of Carboxyamidotriazole, a Calcium Signal Transduction Inhibitor: Toxicity, Bioavailability and the Effect of Food1
Jordan Berlin; Kendra D. Tutsch; Rhoda Z. Arzoomanian; Dona Alberti; Kim Binger; Chris Feierabend; Amy Dresen; Rebecca Marnocha; James Pluda; George Wilding
View articletitled, Phase I and Pharmacokinetic Study of a Micronized Formulation of Carboxyamidotriazole, a Calcium Signal Transduction Inhibitor<span class="subtitle-colon">: </span><span class="subtitle">Toxicity, Bioavailability and the Effect of Food<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup></span>
Open the PDF for in another window
Influence of Amifostine on the Toxicity and Pharmacokinetics of Docetaxel in Metastatic Breast Cancer Patients: A Pilot Study
Gilles Freyer; Philippe Hennebert; Ahmad Awada; Thierry Gil; Joseph Kerger; Jean Selleslags; Christiane Brassinne; Martine Piccart; Dominique de Valeriola
View articletitled, Influence of Amifostine on the Toxicity and Pharmacokinetics of Docetaxel in Metastatic Breast Cancer Patients<span class="subtitle-colon">: </span><span class="subtitle">A Pilot Study</span>
Open the PDF for in another window
Cancer Biology, Immunology, Cytokines
An Orthotopic Nude Mouse Model of Oral Tongue Squamous Cell Carcinoma
Jeffrey N. Myers; F. Christopher Holsinger; Samar A. Jasser; B. Nebiyou Bekele; Isaiah J. Fidler
View articletitled, An Orthotopic Nude Mouse Model of Oral Tongue Squamous Cell Carcinoma
Open the PDF for in another window

Research Articles

Molecular Oncology, Markers, Clinical Correlates
Patterns of Elevation of Plasma 2′-Deoxyuridine, a Surrogate Marker of Thymidylate Synthase (TS) Inhibition, after Administration of Two Different Schedules of 5-Fluorouracil and the Specific TS Inhibitors Raltitrexed (Tomudex) and ZD93311
Hugo E. R. Ford; Fraser Mitchell; David Cunningham; David C. Farrugia; Mark E. Hill; Charlotte Rees; A. Hilary Calvert; Ian R. Judson; Ann L. Jackman
View articletitled, Patterns of Elevation of Plasma 2′-Deoxyuridine, a Surrogate Marker of Thymidylate Synthase (TS) Inhibition, after Administration of Two Different Schedules of 5-Fluorouracil and the Specific TS Inhibitors Raltitrexed (Tomudex) and ZD9331<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Immunohistochemical Variation of Human Equilibrative Nucleoside Transporter 1 Protein in Primary Breast Cancers1
John R. Mackey; Lori L. Jennings; Marilyn L. Clarke; Cheryl L. Santos; Laith Dabbagh; Michaela Vsianska; Sheryl L. Koski; Robert W. Coupland; Stephen A. Baldwin; James D. Young; Carol E. Cass
View articletitled, Immunohistochemical Variation of Human Equilibrative Nucleoside Transporter 1 Protein in Primary Breast Cancers<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Dysregulation of Annexin I Protein Expression in High-Grade Prostatic Intraepithelial Neoplasia and Prostate Cancer1
John S. Kang; Benjamin F. Calvo; Susan J. Maygarden; Laura S. Caskey; James L. Mohler; David K. Ornstein
View articletitled, Dysregulation of Annexin I Protein Expression in High-Grade Prostatic Intraepithelial Neoplasia and Prostate Cancer<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Biopsy Specimen Microvessel Density Is a Useful Prognostic Marker in Patients with T2–4M0 Esophageal Cancer Treated with Chemoradiotherapy1
Shuichi Hironaka; Takahiro Hasebe; Tomoyuki Kamijo; Atsushi Ohtsu; Narikazu Boku; Shigeaki Yoshida; Hiroki Saitoh; Atsushi Ochiai
View articletitled, Biopsy Specimen Microvessel Density Is a Useful Prognostic Marker in Patients with T<sub>2–4</sub>M<sub>0</sub> Esophageal Cancer Treated with Chemoradiotherapy<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Promoter Hypermethylation of Multiple Genes in Nasopharyngeal Carcinoma1
Joseph Kwong; Kwok-Wai Lo; Ka-Fai To; Peter M. L. Teo; Philip J. Johnson; Dolly Poon Huang
View articletitled, Promoter Hypermethylation of Multiple Genes in Nasopharyngeal Carcinoma<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Loss of hMSH2 and hMSH6 Expression Is Frequent in Sporadic Endometrial Carcinomas with Microsatellite Instability: A Population-based Study1
Ingunn Stefansson; Lars A. Akslen; Nicola MacDonald; Andy Ryan; Soma Das; Ian J. Jacobs; Helga B. Salvesen
View articletitled, Loss of hMSH2 and hMSH6 Expression Is Frequent in Sporadic Endometrial Carcinomas with Microsatellite Instability<span class="subtitle-colon">: </span><span class="subtitle">A Population-based Study<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup></span>
Open the PDF for in another window
Matrix Metalloproteinase-7 Expression in Colorectal Cancer Liver Metastases: Evidence for Involvement of MMP-7 Activation in Human Cancer Metastases
Zhao-Shi Zeng; Wei-Ping Shu; Alfred M. Cohen; José G. Guillem
View articletitled, Matrix Metalloproteinase-7 Expression in Colorectal Cancer Liver Metastases<span class="subtitle-colon">: </span><span class="subtitle">Evidence for Involvement of MMP-7 Activation in Human Cancer Metastases</span>
Open the PDF for in another window
Modulation of Biologic Endpoints by Topical Difluoromethylornithine (DFMO), in Subjects at High-Risk for Nonmelanoma Skin Cancer1
Janine G. Einspahr; Mark A. Nelson; Kathylynn Saboda; James Warneke; G. Timothy Bowden; David S. Alberts
View articletitled, Modulation of Biologic Endpoints by Topical Difluoromethylornithine (DFMO), in Subjects at High-Risk for Nonmelanoma Skin Cancer<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Total Levels of Tissue Inhibitor of Metalloproteinases 1 in Plasma Yield High Diagnostic Sensitivity and Specificity in Patients with Colon Cancer1
Mads N. Holten-Andersen; Ib Jarle Christensen; Hans Jørgen Nielsen; Ross W. Stephens; Vibeke Jensen; Ole Haagen Nielsen; Steen Sørensen; Jens Overgaard; Hans Lilja; Adrian Harris; Gillian Murphy; Nils Brünner
View articletitled, Total Levels of Tissue Inhibitor of Metalloproteinases 1 in Plasma Yield High Diagnostic Sensitivity and Specificity in Patients with Colon Cancer<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
p73 Overexpression Is a Prognostic Factor in Patients with Colorectal Adenocarcinoma1
Xiao-Feng Sun
View articletitled, p73 Overexpression Is a Prognostic Factor in Patients with Colorectal Adenocarcinoma<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Impact of Alterations Affecting the p53 Pathway in Bladder Cancer on Clinical Outcome, Assessed by Conventional and Array-based Methods1
Ming-Lan Lu; Friedrik Wikman; Torben F. Orntoft; Elizabeth Charytonowicz; Farhang Rabbani; Zuofeng Zhang; Guido Dalbagni; Kamal S. Pohar; Guopei Yu; Carlos Cordon-Cardo
View articletitled, Impact of Alterations Affecting the p53 Pathway in Bladder Cancer on Clinical Outcome, Assessed by Conventional and Array-based Methods<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Aberrant p53, mdm2, and Proliferation Differ in Glioblastomas from Long-Term Compared with Typical Survivors1
Eric C. Burton; Kathleen R. Lamborn; Peter Forsyth; James Scott; Jason O’Campo; Jane Uyehara-Lock; Michael Prados; Mitchel Berger; Sandra Passe; Joon Uhm; Brian P. O’Neill; Robert B. Jenkins; Ken D. Aldape
View articletitled, Aberrant p53, mdm2, and Proliferation Differ in Glioblastomas from Long-Term Compared with Typical Survivors<sup>1</sup>
Open the PDF for in another window
Detection of Aberrant p16 Methylation in the Serum of Colorectal Cancer Patients1
Hong-Zhi Zou; Bao-Ming Yu; Zhi-Wei Wang; Ji-Yuan Sun; Hui Cang; Fei Gao; Dong Hua Li; Ren Zhao; Guo-Guang Feng; Jing Yi
View articletitled, Detection of Aberrant p16 Methylation in the Serum of Colorectal Cancer Patients<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
PGP9.5 as a Marker for Invasive Colorectal Cancer
Taiji Yamazaki; Kenji Hibi; Tsunenobu Takase; Ekmel Tezel; Hiroshi Nakayama; Yasushi Kasai; Katsuki Ito; Seiji Akiyama; Tetsuro Nagasaka; Akimasa Nakao
View articletitled, PGP9.5 as a Marker for Invasive Colorectal Cancer
Open the PDF for in another window
Correlation of Histology and Molecular Genetic Analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 Astrocytic and Oligodendroglial Tumors1
Keisuke Ueki; Ryo Nishikawa; Yoichi Nakazato; Takanori Hirose; Junko Hirato; Nobuaki Funada; Takamitsu Fujimaki; Shuntaro Hojo; Osami Kubo; Takafumi Ide; Masaaki Usui; Chikayuki Ochiai; Shoichi Ito; Hiroshi Takahashi; Akitake Mukasa; Akio Asai; Takaaki Kirino
View articletitled, Correlation of Histology and Molecular Genetic Analysis of 1p, 19q, 10q, <strong><em>TP53, EGFR, CDK4</em></strong>, and <strong><em>CDKN2A</em></strong> in 91 Astrocytic and Oligodendroglial Tumors<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Experimental Therapeutics, Preclinical Pharmacology
Effects of Nonsteroidal Anti-Inflammatory Agents (NSAIDs) on Ovarian Carcinoma Cell Lines: Preclinical Evaluation of NSAIDs as Chemopreventive Agents1
Cristina Rodríguez-Burford; Mack N. Barnes; Denise K. Oelschlager; Russell B. Myers; Lynya I. Talley; Edward E. Partridge; William E. Grizzle
View articletitled, Effects of Nonsteroidal Anti-Inflammatory Agents (NSAIDs) on Ovarian Carcinoma Cell Lines<span class="subtitle-colon">: </span><span class="subtitle">Preclinical Evaluation of NSAIDs as Chemopreventive Agents<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup></span>
Open the PDF for in another window
Improved Circulating Half-Life and Efficacy of an Antibody-Interleukin 2 Immunocytokine Based on Reduced Intracellular Proteolysis
Stephen D. Gillies; Kin-Ming Lo; Christa Burger; Yan Lan; Thomas Dahl; Wai-Keung Wong
View articletitled, Improved Circulating Half-Life and Efficacy of an Antibody-Interleukin 2 Immunocytokine Based on Reduced Intracellular Proteolysis
Open the PDF for in another window
Cooperative Interaction between Interleukin 10 and Galectin-3 against Liver Ischemia-Reperfusion Injury1
Yong J. Lee; Young K. Song
View articletitled, Cooperative Interaction between Interleukin 10 and Galectin-3 against Liver Ischemia-Reperfusion Injury<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Differences in Therapeutic Indexes of Combination Metronomic Chemotherapy and an Anti-VEGFR-2 Antibody in Multidrug-resistant Human Breast Cancer Xenografts1
Giannoula Klement; Ping Huang; Barbara Mayer; Shane K. Green; Shan Man; Peter Bohlen; Daniel Hicklin; Robert S. Kerbel
View articletitled, Differences in Therapeutic Indexes of Combination Metronomic Chemotherapy and an Anti-VEGFR-2 Antibody in Multidrug-resistant Human Breast Cancer Xenografts<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
In Vitro Schedule-dependent Interactions between the Multitargeted Antifolate LY231514 and Gemcitabine in Human Colon Adenocarcinoma Cell Lines
Anna Tesei; Luca Ricotti; Franca De Paola; Dino Amadori; Giovanni L. Frassineti; Wainer Zoli
View articletitled, <strong><em>In Vitro</em></strong> Schedule-dependent Interactions between the Multitargeted Antifolate LY231514 and Gemcitabine in Human Colon Adenocarcinoma Cell Lines
Open the PDF for in another window
Model of Inhibition of the NPM-ALK Kinase Activity by Herbimycin A1
Francesco Turturro; Marilyn D. Arnold; Audrey Y. Frist; Karen Pulford
View articletitled, Model of Inhibition of the NPM-ALK Kinase Activity by Herbimycin A<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Antitumor Activity of Fibroblast Growth Factors (FGFs) for Medulloblastoma May Correlate with FGF Receptor Expression and Tumor Variant1
Sabine M. Duplan; Yves Théorêt; Rhoda L. Kenigsberg
View articletitled, Antitumor Activity of Fibroblast Growth Factors (FGFs) for Medulloblastoma May Correlate with FGF Receptor Expression and Tumor Variant<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Internalization Property of Interleukin-4 Receptor α Chain Increases Cytotoxic Effect of Interleukin-4 Receptor-targeted Cytotoxin in Cancer Cells1
Koji Kawakami; Mariko Kawakami; Pamela Leland; Raj K. Puri
View articletitled, Internalization Property of Interleukin-4 Receptor α Chain Increases Cytotoxic Effect of Interleukin-4 Receptor-targeted Cytotoxin in Cancer Cells<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
The Chemopreventive Agent Oltipraz Possesses Potent Antiangiogenic Activity in Vitro, ex Vivo, and in Vivo and Inhibits Tumor Xenograft Growth1
Bruce A. Ruggeri; Candy Robinson; Thelma Angeles; John Wilkinson, IV; Margie L. Clapper
View articletitled, The Chemopreventive Agent Oltipraz Possesses Potent Antiangiogenic Activity <strong><em>in Vitro</em></strong>, <strong><em>ex Vivo</em></strong>, and <strong><em>in Vivo</em></strong> and Inhibits Tumor Xenograft Growth<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Targeting Adenovirus to the Serotype 3 Receptor Increases Gene Transfer Efficiency to Ovarian Cancer Cells1
Anna Kanerva; Galina V. Mikheeva; Victor Krasnykh; Candace J. Coolidge; John T. Lam; Parameshwar J. Mahasreshti; Shannon D. Barker; Michael Straughn; Mack N. Barnes; Ronald D. Alvarez; Akseli Hemminki; David T. Curiel
View articletitled, Targeting Adenovirus to the Serotype 3 Receptor Increases Gene Transfer Efficiency to Ovarian Cancer Cells<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Interleukin 4 Receptor-directed Cytotoxin Therapy for Human Head and Neck Squamous Cell Carcinoma in Animal Models1
Scott E. Strome; Koji Kawakami; Danielle Alejandro; Stephen Voss; Jan L. Kasperbauer; Diva Salomao; Lieping Chen; Richard A. Maki; Raj K. Puri
View articletitled, Interleukin 4 Receptor-directed Cytotoxin Therapy for Human Head and Neck Squamous Cell Carcinoma in Animal Models<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Synergistic Effects of Topoisomerase I Inhibitor, 7-ethyl-10-hydroxycamptothecin, and Irradiation in a Cisplatin-resistant Human Small Cell Lung Cancer Cell Line
Hiroyuki Kohara; Masahiro Tabata; Katsuyuki Kiura; Hiroshi Ueoka; Kazuhiko Kawata; Masakazu Chikamori; Keisuke Aoe; Kenichi Chikamori; Akio Matsushita; Mine Harada
View articletitled, Synergistic Effects of Topoisomerase I Inhibitor, 7-ethyl-10-hydroxycamptothecin, and Irradiation in a Cisplatin-resistant Human Small Cell Lung Cancer Cell Line
Open the PDF for in another window

Correction

Correction
View articletitled, Correction
Open the PDF for in another window

Advertisement

Breaking
Pancreatic Cancer Survival Rate Stalls
FDA Bans Red Dye No. 3 in Food
AbbVie Inks Deal for T-Cell Engager
View more recent articles
Latest News
Structural Variants Increase Risk of Pediatric Cancers
South Asian Scholars Urge Action on Cancer Inequities
Greater Certainty of Survival Valued Over Speedier Drug Access
View more recent articles
Research Watch
Bile Acids Modulate T-cell Response and Function in Liver Cancer
The Zinc-Binding Cysteine Proteome Comprises Targetable Cancer Vulnerabilities
Engineered Focal Oncogene Amplifications Drive Transformation and Progression
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1557-3265
  • Print ISSN 1078-0432

AACR Journals

 

 

  • Copyright © 2025 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept